The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
mTOR substrate phosphorylation in growth control
Open accessAbstract
The target of rapamycin (TOR), discovered 30 years ago, is a highly conserved serine/threonine protein kinase that plays a central role in regulating cell growth and metabolism. It is activated by nutrients, growth factors, and cellular energy. TOR forms two structurally and functionally distinct complexes, TORC1 and TORC2. TOR signaling activates cell growth, defined as an increase in biomass, by stimulating anabolic metabolism while inhibiting catabolic processes. With emphasis on mammalian TOR (mTOR), we comprehensively reviewed the literature and identified all reported direct substrates. In the context of recent structural information, we discuss how mTORC1 and mTORC2, despite having a common catalytic subunit, phosphorylate distinct substrates. We conclude that the two complexes recruit different substrates to phosphorylate a common, minimal motif.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
The mucolipidosis IV Ca2+ channel TRPML1 (MCOLN1) is regulated by the TOR kinase
Onyenwoke, R. U., Sexton, J. Z., Yan, F., Díaz, M. C. H., Forsberg, L. J., Major, M. B., & Brenman, J. E. (2015) · Biochemical Journal · doi:10.1042/bj20150219 · Cited by 81
mTOR-mediated phosphorylation of VAMP8 and SCFD1 regulates autophagosome maturation
Huang, H., Ouyang, Q., Zhu, M., Yu, H., Mei, K., & Liu, R. (2021) · Nature Communications · doi:10.1038/s41467-021-26824-5 · Cited by 78
Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis
Viscarra, J. A., Wang, Y., Nguyen, H. P., Choi, Y. G., & Sul, H. S. (2020) · Nature Communications · doi:10.1038/s41467-020-14617-1 · Cited by 77
Substrate specificity of TOR complex 2 is determined by a ubiquitin-fold domain of the Sin1 subunit
Tatebe, H., Murayama, S., Yonekura, T., Hatano, T., Richter, D., Furuya, T., Kataoka, S., Furuita, K., Kojima, C., & Shiozaki, K. (2017) · eLife · doi:10.7554/elife.19594 · Cited by 66
Significance of filamin A in mTORC2 function in glioblastoma
Chantaravisoot, N., Wongkongkathep, P., Loo, J. A., Mischel, P. S., & Tamanoi, F. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0396-z · Cited by 64
Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2
Karuppasamy, M., Kuśmider, B., de Oliveira, T. M., Gaubitz, C., Prouteau, M., Loewith, R., & Schaffitzel, C. (2017) · Nature Communications · doi:10.1038/s41467-017-01862-0 · Cited by 59
Gai, Z., Wang, Q., Yang, C., Wang, L., Deng, W., & Wu, G. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.51 · Cited by 58
Chen, Y., Qian, J., He, Q., Zhao, H., Toral‐Barza, L., Shi, C., Zhang, X., Wu, J., & Yu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.8279 · Cited by 56
Hwang, Y., Kim, L. C., Song, W., Edwards, D. N., Cook, R. S., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3658 · Cited by 54
Keshwani, M. M., von Daake, S., Newton, A. C., Harris, T. K., & Taylor, S. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258004 · Cited by 50
Dokládal, L., Stumpe, M., Hu, Z., Jaquenoud, M., Dengjel, J., & VIRGILIO, C. D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110149 · Cited by 48
Regulation of human mTOR complexes by DEPTOR
Wälchli, M., Berneiser, K., Mangia, F., Imseng, S., Craigie, L.-M., Stuttfeld, E., Hall, M. N., & Maier, T. (2021) · eLife · doi:10.7554/elife.70871 · Cited by 46
Self-citationMoloughney, J. G., Vega-Cotto, N. M., Liu, S., Patel, C., Kim, P. K., Wu, C., Albaciete, D., Magaway, C., Chang, A. B., Rajput, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003991 · Cited by 45
PIP4kγ is a substrate for mTORC1 that maintains basal mTORC1 signaling during starvation
Mackey, A. M., Sarkes, D. A., Bettencourt, I. A., Asara, J. M., & Rameh, L. E. (2014) · Science Signaling · doi:10.1126/scisignal.2005191 · Cited by 44
Langer, L. M., Gat, Y., Bonneau, F., & Conti, E. (2020) · eLife · doi:10.7554/elife.57127 · Cited by 42
Ando, R., Shima, H., Tamahara, T., Sato, Y., Watanabe‐Matsui, M., Kato, H., Sax, N., Motohashi, H., Taguchi, K., Yamamoto, M. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661702 · Cited by 41
The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids
Hoxhaj, G., Caddye, E., Najafov, A., Houde, V. P., Johnson, C., Dissanayake, K., Toth, R. L., Campbell, D. G., Prescott, A. R., & MacKintosh, C. (2016) · eLife · doi:10.7554/elife.12278 · Cited by 41
Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates
Chao, L. H., & Avruch, J. (2019) · F1000Research · doi:10.12688/f1000research.16109.1 · Cited by 41
Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways
Cho, J. H., Kim, K., Kim, S., Park, B.-O., Park, B.-O., Kim, J.-H., Kim, S., Kwon, M. J., Han, M., Lee, S. B., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00649-z · Cited by 39
Xia, J., Wang, R., Zhang, T., & Ding, J. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.35 · Cited by 38
Yang, C., Melhuish, T. A., Spencer, A., Li, N., Hao, Y., Jividen, K., Harris, T. E., Snow, C. J., Frierson, H. F., Wotton, D., et al. (2017) · The Prostate · doi:10.1002/pros.23400 · Cited by 37
Langer, L. M., Bonneau, F., Gat, Y., & Conti, E. (2021) · eLife · doi:10.7554/elife.72353 · Cited by 36
Activating Mutations in TOR Are in Similar Structures As Oncogenic Mutations in PI3KCα
Sturgill, T. W., & Hall, M. N. (2009) · ACS Chemical Biology · doi:10.1021/cb900193e · Cited by 35
Self-citationRegulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals
Sengupta, S., Lorente-Rodríguez, A., Earnest, S. A., Stippec, S., Guo, X., Trudgian, D. C., Mirzaei, H., & Cobb, M. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318676110 · Cited by 35
RagC phosphorylation autoregulates mTOR complex 1
Yang, G., Humphrey, S. J., Murashige, D., Francis, D., Wang, Q., Cooke, K. C., Neely, G. G., & James, D. E. (2018) · The EMBO Journal · doi:10.15252/embj.201899548 · Cited by 35
Activation of PASK by mTORC1 is required for the onset of the terminal differentiation program
Kikani, C. K., Wu, X., Fogarty, S., Kang, S. A., Dephoure, N., Gygi, S. P., Sabatini, D. M., & Rutter, J. P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804013116 · Cited by 35
mTOR Signaling Regulates Nucleolar Targeting of the SUMO-Specific Isopeptidase SENP3
Raman, N., Nayak, A., & Müller, S. P. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00801-14 · Cited by 34
Holmes, B., Benavides-Serrato, A., Saunders, J. T., Kumar, S., Nishimura, R. N., & Gera, J. (2021) · Neoplasia · doi:10.1016/j.neo.2021.07.005 · Cited by 34
Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis
Ren, Q., Zhang, H., Sun, C., Zhou, Y., Yang, X., Long, J., Li, X., Mai, S., Zhang, M., Zhang, H., et al. (2021) · Hepatology · doi:10.1002/hep.32120 · Cited by 34
Regulation of a Third Conserved Phosphorylation Site in SGK1
Chen, W., Chen, Y., Xu, B.-E., Juang, Y.-C. A., Stippec, S., Zhao, Y., & Cobb, M. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807502200 · Cited by 33
Dawson, J. E., Bah, A., Zhang, Z., Vernon, R. M., Lin, H., Chong, P. A., Vanama, M. S., Sonenberg, N., Gradinaru, C. C., & Forman-Kay, J. D. (2020) · Nature Communications · doi:10.1038/s41467-020-16783-8 · Cited by 33
Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation Stabilizes ISCU Protein
La, P., Yang, G., & Dennery, P. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.424499 · Cited by 30
Benavides-Serrato, A., Anderson, L., Holmes, B., Cloninger, C., Artinian, N., Bashir, T., & Gera, J. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.41 · Cited by 27
Tao, Z., Barker, J., Shi, S. D. ‐., Gehring, M. R., & Sun, S. (2010) · Biochemistry · doi:10.1021/bi100673c · Cited by 27
Schwarz, J., Wiese, H., Tölle, R. C., Zarei, M., Dengjel, J., Warscheid, B., & Thedieck, K. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.045807 · Cited by 24
Batool, A., Majeed, S. T., Aashaq, S., Majeed, R., Bhat, N. N., & Andrabi, K. I. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03663-z · Cited by 19
Majeed, S. T., Batool, A., Majeed, R., Bhat, N. N., Zargar, M. A., & Andrabi, K. I. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1901038 · Cited by 19
Marshall, M. N. M., Emmerstorfer‐Augustin, A., Leskoske, K. L., Zhang, L. H., Li, B., & Thorner, J. W. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-10-0682 · Cited by 18
Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace
Heimhalt, M., Berndt, A., Wagstaff, J. L., Anandapadamanaban, M., Perišić, O., Maslen, S., McLaughlin, S. H., Yu, C. W.-H., Masson, G. R., Boland, A., et al. (2021) · eLife · doi:10.7554/elife.68799 · Cited by 18
Cited by
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Shetty, S., Hofstetter, J., Battaglioni, S., Ritz, D., & Hall, M. N. (2023) · The EMBO Journal · doi:10.15252/embj.2022112344 · Cited by 58
Self-citationAhmad, Y., Seo, D. S., & Jang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137076 · Cited by 49
Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations
Kraft, M., Schoofs, H., Petkova, M., Andrade, J., Grosso, A. R., Benedito, R., De Roo, A.-K., Boon, L. M., Vikkula, M., Kapp, F. G., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00655-9 · Cited by 28
Research progress on interferon and cellular senescence
Wang, D., Chen, K., Wang, Z., Wu, H., & Li, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400808rr · Cited by 23
Metadata
- Authors
- Battaglioni, S., Benjamin, D., Wälchli, M., Maier, T., & Hall, M. N.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 185
- Issue
- 11
- Pages
- 1814-1836
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4280560201
- Cited by
- 434
- References
- 239
- FWCI
- 24.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.